Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
American Journal of Translational Research|October 12, 2020
FOXA2 promotes prostate cancer growth in the boneZachary M Connelly, Renjie Jin, Jianghong Zhang, et al.
Development (Cambridge, England)|July 1, 2005
Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturationNan Gao, Kenichiro Ishii, Janni Mirosevich, et al.
Molecular Cancer Therapeutics|December 10, 2020
Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells <i>In Vitro</i>Sarah E Kohrt, Wisam N Awadallah, Robert A Phillips, et al.
Prostate Cancer and Prostatic Diseases|April 22, 2020
The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancerSiyuan Cheng, Nestor Prieto-Dominguez, Shu Yang, et al.
Cancer Research|August 15, 2008
The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growthRen Jie Jin, Yongsoo Lho, Linda Connelly, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 21, 2014
FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotypeDavid J DeGraff, Magdalena M Grabowska, Tom C Case, et al.
American Journal of Physiology. Cell Physiology|April 17, 2025
Fibronectin-dependent integrin signaling drives EphA2 expression in vascular smooth muscle cellsBrenna Pearson-Gallion, Alexandra C Finney, Matthew L Scott, et al.
Plos One|May 17, 2012
Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferationDavid J DeGraff, Peter E Clark, Justin M Cates, et al.
Molecular Endocrinology (Baltimore, Md.)|May 8, 2014
NFI transcription factors interact with FOXA1 to regulate prostate-specific gene expressionMagdalena M Grabowska, Amicia D Elliott, David J DeGraff, et al.
Communications Biology|November 18, 2020
Methamphetamine induces cardiomyopathy by Sigmar1 inhibition-dependent impairment of mitochondrial dynamics and functionChowdhury S Abdullah, Richa Aishwarya, Shafiul Alam, et al.
Pageof 9